![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 19118 |
FusionGeneSummary for KMT2C_CNTNAP2 |
![]() |
Fusion gene information | Fusion gene name: KMT2C_CNTNAP2 | Fusion gene ID: 19118 | Hgene | Tgene | Gene symbol | KMT2C | CNTNAP2 | Gene ID | 58508 | 26047 |
Gene name | lysine methyltransferase 2C | contactin associated protein like 2 | |
Synonyms | HALR|KLEFS2|MLL3 | AUTS15|CASPR2|CDFE|NRXN4|PTHSL1 | |
Cytomap | 7q36.1 | 7q35-q36.1 | |
Type of gene | protein-coding | protein-coding | |
Description | histone-lysine N-methyltransferase 2CALR-like proteinhistone-lysine N-methyltransferase MLL3histone-lysine N-methyltransferase, H3 lysine-4 specifichomologous to ALR proteinlysine (K)-specific methyltransferase 2Cmyeloid/lymphoid or mixed-lineage le | contactin-associated protein-like 2cell recognition molecule Caspr2homolog of Drosophila neurexin IV | |
Modification date | 20180523 | 20180519 | |
UniProtAcc | Q8NEZ4 | Q9UHC6 | |
Ensembl transtripts involved in fusion gene | ENST00000262189, ENST00000355193, ENST00000485655, ENST00000485241, | ENST00000361727, ENST00000538075, ENST00000463592, | |
Fusion gene scores | * DoF score | 18 X 16 X 10=2880 | 8 X 8 X 7=448 |
# samples | 22 | 9 | |
** MAII score | log2(22/2880*10)=-3.71049338280502 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(9/448*10)=-2.31550182572793 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: KMT2C [Title/Abstract] AND CNTNAP2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation | Tumor suppressor gene involved fusion gene, retained protein feature but frameshift. DDR (DNA damage repair) gene involved fusion gene, in-frame but not retained their domain. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | BRCA | TCGA-BH-A0DI-01A | KMT2C | chr7 | 152027686 | - | CNTNAP2 | chr7 | 146740999 | + |
TCGA | LD | BRCA | TCGA-C8-A273-01A | KMT2C | chr7 | 152132711 | - | CNTNAP2 | chr7 | 146471363 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000262189 | ENST00000361727 | KMT2C | chr7 | 152027686 | - | CNTNAP2 | chr7 | 146740999 | + |
5CDS-intron | ENST00000262189 | ENST00000538075 | KMT2C | chr7 | 152027686 | - | CNTNAP2 | chr7 | 146740999 | + |
5CDS-intron | ENST00000262189 | ENST00000463592 | KMT2C | chr7 | 152027686 | - | CNTNAP2 | chr7 | 146740999 | + |
Frame-shift | ENST00000355193 | ENST00000361727 | KMT2C | chr7 | 152027686 | - | CNTNAP2 | chr7 | 146740999 | + |
5CDS-intron | ENST00000355193 | ENST00000538075 | KMT2C | chr7 | 152027686 | - | CNTNAP2 | chr7 | 146740999 | + |
5CDS-intron | ENST00000355193 | ENST00000463592 | KMT2C | chr7 | 152027686 | - | CNTNAP2 | chr7 | 146740999 | + |
intron-3CDS | ENST00000485655 | ENST00000361727 | KMT2C | chr7 | 152027686 | - | CNTNAP2 | chr7 | 146740999 | + |
intron-intron | ENST00000485655 | ENST00000538075 | KMT2C | chr7 | 152027686 | - | CNTNAP2 | chr7 | 146740999 | + |
intron-intron | ENST00000485655 | ENST00000463592 | KMT2C | chr7 | 152027686 | - | CNTNAP2 | chr7 | 146740999 | + |
intron-3CDS | ENST00000485241 | ENST00000361727 | KMT2C | chr7 | 152027686 | - | CNTNAP2 | chr7 | 146740999 | + |
intron-intron | ENST00000485241 | ENST00000538075 | KMT2C | chr7 | 152027686 | - | CNTNAP2 | chr7 | 146740999 | + |
intron-intron | ENST00000485241 | ENST00000463592 | KMT2C | chr7 | 152027686 | - | CNTNAP2 | chr7 | 146740999 | + |
Frame-shift | ENST00000262189 | ENST00000361727 | KMT2C | chr7 | 152132711 | - | CNTNAP2 | chr7 | 146471363 | + |
5CDS-intron | ENST00000262189 | ENST00000538075 | KMT2C | chr7 | 152132711 | - | CNTNAP2 | chr7 | 146471363 | + |
5CDS-intron | ENST00000262189 | ENST00000463592 | KMT2C | chr7 | 152132711 | - | CNTNAP2 | chr7 | 146471363 | + |
Frame-shift | ENST00000355193 | ENST00000361727 | KMT2C | chr7 | 152132711 | - | CNTNAP2 | chr7 | 146471363 | + |
5CDS-intron | ENST00000355193 | ENST00000538075 | KMT2C | chr7 | 152132711 | - | CNTNAP2 | chr7 | 146471363 | + |
5CDS-intron | ENST00000355193 | ENST00000463592 | KMT2C | chr7 | 152132711 | - | CNTNAP2 | chr7 | 146471363 | + |
intron-3CDS | ENST00000485655 | ENST00000361727 | KMT2C | chr7 | 152132711 | - | CNTNAP2 | chr7 | 146471363 | + |
intron-intron | ENST00000485655 | ENST00000538075 | KMT2C | chr7 | 152132711 | - | CNTNAP2 | chr7 | 146471363 | + |
intron-intron | ENST00000485655 | ENST00000463592 | KMT2C | chr7 | 152132711 | - | CNTNAP2 | chr7 | 146471363 | + |
intron-3CDS | ENST00000485241 | ENST00000361727 | KMT2C | chr7 | 152132711 | - | CNTNAP2 | chr7 | 146471363 | + |
intron-intron | ENST00000485241 | ENST00000538075 | KMT2C | chr7 | 152132711 | - | CNTNAP2 | chr7 | 146471363 | + |
intron-intron | ENST00000485241 | ENST00000463592 | KMT2C | chr7 | 152132711 | - | CNTNAP2 | chr7 | 146471363 | + |
Top |
FusionProtFeatures for KMT2C_CNTNAP2 |
![]() |
Hgene | Tgene |
KMT2C | CNTNAP2 |
Histone methyltransferase. Methylates 'Lys-4' of histoneH3. H3 'Lys-4' methylation represents a specific tag forepigenetic transcriptional activation. Central component of theMLL2/3 complex, a coactivator complex of nuclear receptors,involved in transcriptional coactivation. KMT2C/MLL3 may be acatalytic subunit of this complex. May be involved inleukemogenesis and developmental disorder.{ECO:0000269|PubMed:17500065}. | Required, with CNTNAP1, for radial and longitudinalorganization of myelinated axons. Plays a role in the formation offunctional distinct domains critical for saltatory conduction ofnerve impulses in myelinated nerve fibers. Demarcates thejuxtaparanodal region of the axo-glial junction.{ECO:0000250|UniProtKB:Q9CPW0}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for KMT2C_CNTNAP2 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for KMT2C_CNTNAP2 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
KMT2C | AK1, NCOA6, ASH2L, RBBP5, HIST2H3C, ASCL2, KDM6A, SMARCB1, MAPK14, JUN, PAXIP1, H3F3A, PAGR1, WDR82, CDC73, TSC22D1, KDM4B, ELAVL1, WDR5, HIST1H3A, APPL2, ERP44, HIST3H3, DPY30, MTNR1B, FOXA1, TRIM25 | CNTNAP2 | CNTN2, EPB41L3, CASK, CTR9, ZMIZ1, MACF1, IQCB1, MEOX2 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for KMT2C_CNTNAP2 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for KMT2C_CNTNAP2 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | KMT2C | C0001418 | Adenocarcinoma | 1 | CTD_human |
Hgene | KMT2C | C0005695 | Bladder Neoplasm | 1 | CTD_human |
Hgene | KMT2C | C0007138 | Carcinoma, Transitional Cell | 1 | CTD_human |
Hgene | KMT2C | C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
Hgene | KMT2C | C0023467 | Leukemia, Myelocytic, Acute | 1 | CTD_human |
Hgene | KMT2C | C0023897 | Liver Diseases, Parasitic | 1 | CTD_human |
Hgene | KMT2C | C0036920 | Sezary Syndrome | 1 | CTD_human |
Hgene | KMT2C | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Hgene | KMT2C | C0206698 | Cholangiocarcinoma | 1 | CTD_human |
Hgene | KMT2C | C0279626 | Squamous cell carcinoma of esophagus | 1 | CTD_human |
Hgene | KMT2C | C2239176 | Liver carcinoma | 1 | CTD_human |
Tgene | CNTNAP2 | C0004352 | Autistic Disorder | 4 | CTD_human |
Tgene | CNTNAP2 | C1510586 | Autism Spectrum Disorders | 4 | CTD_human |
Tgene | CNTNAP2 | C0023014 | Language Development Disorders | 3 | CTD_human |
Tgene | CNTNAP2 | C0014544 | Epilepsy | 2 | CTD_human;HPO |
Tgene | CNTNAP2 | C0001973 | Alcoholic Intoxication, Chronic | 1 | PSYGENET |
Tgene | CNTNAP2 | C0005586 | Bipolar Disorder | 1 | PSYGENET |
Tgene | CNTNAP2 | C0036341 | Schizophrenia | 1 | CTD_human |
Tgene | CNTNAP2 | C0038506 | Stuttering | 1 | CTD_human |
Tgene | CNTNAP2 | C0041696 | Unipolar Depression | 1 | PSYGENET |
Tgene | CNTNAP2 | C0149925 | Small cell carcinoma of lung | 1 | CTD_human |
Tgene | CNTNAP2 | C0424295 | Hyperactive behavior | 1 | CTD_human;HPO |
Tgene | CNTNAP2 | C1269683 | Major Depressive Disorder | 1 | PSYGENET |
Tgene | CNTNAP2 | C1970431 | PITT-HOPKINS SYNDROME | 1 | CTD_human |